Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • giorgifm
    Member
    • Aug 2011
    • 35

    #1

    Differential expression analysis on RPKMs - Contrasts and contrasts of contrasts

    Dear all,

    I'm looking for a tool (better would be a Bioconductor package) able to perform differential expression analysis on a table of RPKMs. I've seen so far only solutions implementing raw read counts, like DEGSeq, edgeR and BaySeq. And yeah, in this particular case I cannot transform RPKMs back to read counts.

    Do you have any idea? Furthermore, a great advantage would be the capability of calculating significance of "contrasts of contrasts" analysis, i.e. of tetrafactorial designs.

    E.g. having 4 conditions: WT control, WT treated, mutant control, mutant treated.

    Code:
    DE1 = WT treated vs. WT control
    DE2 = mutant treated vs. mutant control
    
    DE1DE2 = (mutant trated vs. mutant control) vs. (WT treated vs. WT control)
    Something like the great limma does for microarrays. But on RNASeq RPKMs.
    Thanks a lot for any hint!
  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #2
    Why can't you extract the raw read counts?

    Comment

    • peer.b
      Junior Member
      • Oct 2011
      • 5

      #3
      It's unfortunately an issue sometimes, since in the beginning RPKM (Mortazavi et al., 2008) were considered a standard and some softwares (e.g. Cufflinks) by default output only FPKM and pairwise condition comparisons. There's an open (more like a closed now) debate on whether one should use RPKM or raw read counts for differential analysis, the latter being the prime choice for statistical reason (see for example the manuals of edgeR and the wiki of this website).
      As for your question, given only a table of RPKM, you can try the NOISeq R script (http://bioinfo.cipf.es/noiseq/doku.php?id=tutorial), if you can manage to convince it that your data is already rpkm-normalized. Good luck!

      Comment

      • Simon Anders
        Senior Member
        • Feb 2010
        • 995

        #4
        Any valid statistical analysis which only get RPKM values as input will have very little power, because lacking information on whether a certain count value stems from a long gene with many counts or a short gene with few counts, it is bound to assume that all numbers stem from low-count and hence high-variance genes.

        I'd be careful with NOISeq, by the way. In the paper on NOISeq, the method is evaluated only on dataset that contain no replicates or only technical replicates, i.e., it is not shown that this method is able to correctly assess biological variability and hence control type-I error rate in a biologically meaningful way.

        Comment

        • dietmar13
          Senior Member
          • Mar 2010
          • 107

          #5
          NOIseq fails

          in my hands NOIseq on RAW read counts failed to get significant DE genes called (i.e. only VERY few called), similar to tophat/cuffdiff (only 2 DE genes called) if comparing 12 normal vs 12 colon cancer samples. DESeq, edgeR, BaySeq, SAMseq worked much better...

          with edgeR and limma (design matrix) you can analyse your design (wt-mock, wt-treat, mut-mock, mut-treat), but you need raw reads...

          Comment

          • giorgifm
            Member
            • Aug 2011
            • 35

            #6
            Thanks everyone for your super-informative answers. I guess I will have to convince my collaborators to move towards raw read counts then.

            Comment

            • Richard Fox
              Junior Member
              • Aug 2013
              • 1

              #7
              Check out a recent comparison of methods:

              Nookaew et. al. (2012), Nucleic Acids Research, Vol. 40, 10084-10097.

              NOISeq does not lack power and compares well with other methods as well as microarrays.

              “Although all the methods were in agreement in identifying significant GO terms related to growth (a consequence of the increased specific growth rate during batch cultivations), GO terms known to be relevant during fully respiratory growth are not all in agreement with the different methods. Specifically, edgeR showed some inconsistencies in capturing GO terms associated with fatty acid beta-oxidation terms (as well as DESeq), fatty acid metabolic process and TCA cycle, whereas baySeq weakly identify increased expression of ATP-coupled proton transport and ion transport. Interestingly, the results derived from NOISeq seem to give stronger signals that explain the known differences between batch and chemostat growth better than the results derived from the other methods.”

              The authors speculate that edgeR suffers from increased Type I error.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
                by SEQadmin2



                Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

                Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
                ...
                Yesterday, 09:55 AM
              • SEQadmin2
                New Genomics Technologies Take Aim at Long-Standing Limits
                by SEQadmin2


                Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

                We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
                ...
                09-28-2026, 10:25 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Today, 10:52 AM
              0 responses
              8 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, Yesterday, 05:39 AM
              0 responses
              17 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-13-2026, 09:56 AM
              0 responses
              15 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 10-09-2026, 11:14 AM
              0 responses
              27 views
              0 reactions
              Last Post SEQadmin2  
              Working...